Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia

The clinical course of the new coronavirus disease 2019 (COVID-19) has shown that patients with chronic lymphocytic leukemia (CLL) are characterized by a high mortality rate, poor response to standard treatment, and low virus-specific antibody response after recovery and/or vaccination. To date, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Komissarov, Alexey A., Kislova, Maria, Molodtsov, Ivan A., Petrenko, Andrei A., Dmitrieva, Elena, Okuneva, Maria, Peshkova, Iuliia O., Shakirova, Naina T., Potashnikova, Daria M., Tvorogova, Anna V., Ptushkin, Vadim V., Efimov, Grigory A., Nikitin, Eugene A., Vasilieva, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820366/
https://www.ncbi.nlm.nih.gov/pubmed/36613860
http://dx.doi.org/10.3390/ijms24010416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820366/
https://www.ncbi.nlm.nih.gov/pubmed/36613860
http://dx.doi.org/10.3390/ijms24010416

Ejemplares similares